http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DD-249482-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3bfedd8ba4800708cecfd357707f8f67
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-38
filingDate 1986-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d71cbd8e35b8b9462dcfe18c4f6b74dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_315bc8080d208fc33da84e1f529b547c
publicationDate 1987-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DD-249482-A1
titleOfInvention PROCESS FOR PREPARING FORMAMIDINOMETHANE-BISPHOSPHONIC ACID AND AMINOMETHANE-BISPHOSPHONIC ACID
abstract It is an object of the invention to provide a process by which formamidinomethane and aminomethane bisphosphonic acid can be prepared in high yields from starting materials which are technically easily accessible, cheap and, if possible, without the use of chlorine-containing and highly toxic starting materials which require a high level of safety. The object of the invention is the development of a process with which phosphoric (III) oxide (P4O6), phosphoric acid and formamide can be used to produce formamidinomethane and aminomethane bisphosphonic acid in high yields. According to the invention, a mixture of P4O6, anhydrous H3PO4 and formamide having a molar ratio between 1: 1: 1 and 1: 3: 3 is reacted at 300 K to 400 K and the reaction mixture is hydrolyzed with water or an inorganic acid, and the formamidinomethanebisphosphonic acid formed crystallizes out the solution is isolated, or-hydrolyzed in a conventional manner in an alkaline solution and the Aminomethanbisphosphonsaeure isolated by crystallization from an acidic solution. Yields of 75% to 85% are obtained.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-3700772-A1
priorityDate 1986-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20569098
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID405383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415823637
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID768
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID713
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123317
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID140819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123290
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID34669
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410778979
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559532
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24404
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520343
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415958069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410510985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14797
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410697574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410493559
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457569339
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451326755
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1004

Total number of triples: 42.